Key Takeaways
- • PharVision Capital, the hedge fund run by ex-Citadel trader Blago Baychev, posted a 6% gain in September 2026, turning positive for the year after a difficult period, according to Financial News London.
- • The fund attributes its performance to its use of artificial intelligence in trading, per the article's account of the firm's results.
- • The September result comes as global hedge funds posted mixed returns amid surging bond yields, higher oil prices and volatility in AI-related equities, according to publisher coverage.
- • Citadel's flagship Wellington fund ended September up 1.1%, leaving it 13.4% higher for the year, while Balyasny rose 0.1% and Millennium was also cited in the same reporting.
Summary
Blago Baychev's PharVision Capital gained 6% in September 2026, according to Financial News London, returning the fund to positive territory for the year after a tough period. The article, written by Bilal Jafar, credits the firm's use of artificial intelligence in its investment process for the result. Baychev is a former Citadel trader.
The September gain stands against a mixed backdrop for the hedge fund industry. Publisher coverage reports that global hedge funds delivered mixed results in September as surging bond yields, higher oil prices and swings in AI shares drove selling. Citadel's flagship Wellington fund ended the month up 1.1%, leaving it 13.4% higher for the year. Balyasny rose 0.1% in September, and Millennium was also covered in the same reporting.
AI-focused equities have been a major source of volatility for the sector this year. Publisher coverage of Citadel's July performance noted that the firm's flagship fund surged 5.9% that month after buying a discounted portfolio of AI stocks from the troubled hedge fund Situational Awareness, a transaction widely viewed as providing liquidity during a period of heightened AI-stock volatility. That July episode is separate from PharVision's September results and is cited here only as background.
For allocators, PharVision's September performance is notable mainly as a data point on how AI-driven strategies are performing through periods of sector-wide stress, though the article provides limited detail on the fund's size, strategy mechanics or year-to-date return figure.
The September gain stands against a mixed backdrop for the hedge fund industry. Publisher coverage reports that global hedge funds delivered mixed results in September as surging bond yields, higher oil prices and swings in AI shares drove selling. Citadel's flagship Wellington fund ended the month up 1.1%, leaving it 13.4% higher for the year. Balyasny rose 0.1% in September, and Millennium was also covered in the same reporting.
AI-focused equities have been a major source of volatility for the sector this year. Publisher coverage of Citadel's July performance noted that the firm's flagship fund surged 5.9% that month after buying a discounted portfolio of AI stocks from the troubled hedge fund Situational Awareness, a transaction widely viewed as providing liquidity during a period of heightened AI-stock volatility. That July episode is separate from PharVision's September results and is cited here only as background.
For allocators, PharVision's September performance is notable mainly as a data point on how AI-driven strategies are performing through periods of sector-wide stress, though the article provides limited detail on the fund's size, strategy mechanics or year-to-date return figure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.